MK-251
MK-251 is an orally active anti-arrhythmic agent. MK-251 prevents or modifies ventricular arrhythmias induced in dogs and baboons by tetrafluorethylbutylamine. MK-251 antagonizes the arrhythmias caused by Digoxin in cats. MK-251 at effective doses has little effect on basic cardiovascular parameters such as blood pressure, cardiac output, myocardial contractility and ventricular conduction, thus demonstrating its unique advantages[1].
Product Specifications
CAS Number
36386-71-7
UNSPSC
12352005
Target
Others
Related Pathways
Others
Field of Research
Cardiovascular Disease
Smiles
FC(C1=CC=CC=C1)(C(F)(C2=CC=C(C(C)(C)N)C=C2)F)F
Molecular Formula
C17H17F4N
Molecular Weight
311.32
References & Citations
[1]Torchiana ML, et al. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4- (alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251) . J Pharmacol Exp Ther. 1975 Aug;194 (2) :415-26.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
228093 200 µg
CD38 (T10, ADP-Ribosyl Cyclase, Cyclic ADP-Ribose Hydrolase) (PE) discontinued
Sign In for Pricing
View Details 
